drugset / Trial / NCT01002859

Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

NCT01002859 ↗

Phase 2 Terminated 50 enrolled University Hospital, Grenoble
RandomizedParallel-groupDouble-blindPrevention

Summary

Observe the effect of preliminary cyclosporine administration on different markers of cardiac ischaemia led by the aortic cross-clamp during coronary artery bypass surgery with Cardiopulmonary bypass.

Timeline

Start
2009-04
Primary completion
2011-05
Completion
2011-07

Outcome

Outcome not reported

Stopped: “difficulties to include patients”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sandimmum Unknown — Intravenous

Indications

No indication recorded.